Aehr Test Systems (NASDAQ:AEHR) Releases FY 2024 Earnings Guidance

Aehr Test Systems (NASDAQ:AEHR) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share guidance of 0.480- for the period, compared to the consensus earnings per share estimate of 0.760. The company issued revenue guidance of $65.0 million-$65.0 million, compared to the consensus revenue estimate of $77.4 million. Aehr Test Systems also updated its Q3 2024 guidance to -0.040–0.030 EPS.

Aehr Test Systems Stock Up 11.5 %

Shares of Aehr Test Systems stock opened at $12.46 on Thursday. Aehr Test Systems has a 52 week low of $10.53 and a 52 week high of $54.10. The firm’s 50 day moving average is $15.92 and its two-hundred day moving average is $25.51. The firm has a market capitalization of $359.47 million, a P/E ratio of 17.55 and a beta of 2.01.

Aehr Test Systems (NASDAQ:AEHR) last posted its earnings results on Tuesday, January 9th. The semiconductor company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Aehr Test Systems had a net margin of 25.76% and a return on equity of 26.97%. The firm had revenue of $21.43 million for the quarter, compared to the consensus estimate of $20.10 million. As a group, research analysts expect that Aehr Test Systems will post 0.72 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on AEHR shares. William Blair reaffirmed a market perform rating on shares of Aehr Test Systems in a report on Monday. Craig Hallum reiterated a hold rating and issued a $12.00 price target on shares of Aehr Test Systems in a research report on Tuesday. Finally, StockNews.com raised Aehr Test Systems from a sell rating to a hold rating in a research note on Friday, January 19th.

Insiders Place Their Bets

In related news, CEO Gayn Erickson sold 4,871 shares of the company’s stock in a transaction that occurred on Thursday, January 18th. The shares were sold at an average price of $17.39, for a total transaction of $84,706.69. Following the transaction, the chief executive officer now owns 427,935 shares of the company’s stock, valued at $7,441,789.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Aehr Test Systems news, VP Avijit K. Ray-Chaudhuri acquired 3,000 shares of the company’s stock in a transaction on Friday, January 12th. The shares were bought at an average cost of $17.87 per share, for a total transaction of $53,610.00. Following the acquisition, the vice president now directly owns 9,719 shares of the company’s stock, valued at $173,678.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gayn Erickson sold 4,871 shares of the stock in a transaction that occurred on Thursday, January 18th. The shares were sold at an average price of $17.39, for a total value of $84,706.69. Following the transaction, the chief executive officer now owns 427,935 shares of the company’s stock, valued at $7,441,789.65. The disclosure for this sale can be found here. Insiders have sold 8,738 shares of company stock valued at $151,723 in the last ninety days. Insiders own 6.30% of the company’s stock.

Institutional Trading of Aehr Test Systems

Several institutional investors have recently added to or reduced their stakes in the stock. Lazard Asset Management LLC acquired a new stake in Aehr Test Systems during the fourth quarter valued at approximately $34,000. Deutsche Bank AG acquired a new stake in shares of Aehr Test Systems during the 1st quarter valued at approximately $40,000. PNC Financial Services Group Inc. lifted its stake in Aehr Test Systems by 93.0% during the second quarter. PNC Financial Services Group Inc. now owns 1,158 shares of the semiconductor company’s stock worth $48,000 after purchasing an additional 558 shares during the last quarter. Citigroup Inc. boosted its holdings in Aehr Test Systems by 463.8% in the fourth quarter. Citigroup Inc. now owns 2,458 shares of the semiconductor company’s stock worth $49,000 after purchasing an additional 2,022 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in Aehr Test Systems by 1,027.1% during the first quarter. JPMorgan Chase & Co. now owns 1,578 shares of the semiconductor company’s stock valued at $49,000 after purchasing an additional 1,438 shares during the last quarter. 69.69% of the stock is owned by institutional investors and hedge funds.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.